| To treat or not to treat: Patient exclusion in immune oncology clinical trials due to preexisting autoimmune disease M Pantuck, D McDermott, A Drakaki Cancer 125 (20), 3506-3513, 2019 | 31 | 2019 |
| VEGF inhibition in urothelial cancer: the past, present and future S Ghafouri, A Burkenroad, M Pantuck, B Almomani, D Stefanoudakis, ... World Journal of Urology 39, 741-749, 2021 | 16 | 2021 |
| Risk factors for infection after prostate biopsy in the United States JE Shoag, C Gaffney, M Pantuck, T Sun, M Gorin, E Schaeffer, ... Urology 138, 113-118, 2020 | 16 | 2020 |
| Comparative effectiveness and tolerability of transperineal MRI-targeted prostate biopsy under local versus sedation E Cricco-Lizza, RNWV Berg, A Laviana, M Pantuck, SP Basourakos, ... Urology 155, 33-38, 2021 | 11 | 2021 |
| Symptomatic improvement of lower urinary tract symptoms of benign prostatic hyperplasia: a comparative systematic review and meta-analysis of 4 different minimally invasive … S LaRussa, M Pantuck, RWV Berg, CD Gaffney, G Askin, T McClure Journal of Vascular and Interventional Radiology 32 (9), 1328-1340. e11, 2021 | 10 | 2021 |
| Next generation T-cell therapy for genitourinary malignancies, part A: Introduction and current state of the art M Pantuck, N Palaskas, A Drakaki Cancer Treatment and Research Communications 17, 8-12, 2018 | 7 | 2018 |
| IDEAL Stage 2a experience with in-office, transperineal MRI/ultrasound software fusion targeted prostate biopsy M Tzeng, E Cricco-Lizza, BAH Al Awamlh, M Pantuck, DJ Margolis, M Yu, ... BMJ Surgery, Interventions, & Health Technologies 1 (1), 2019 | 4 | 2019 |
| Next generation T-cell therapy for genitourinary malignancies, part B: Overcoming obstacles and future strategies for success M Pantuck, N Palaskas, A Drakaki Cancer Treatment and Research Communications 17, 1-7, 2018 | 4 | 2018 |
| Risk factors for postprostate biopsy infection. J Shoag, T Sun, M Pantuck, MA Gorin, EM Schaeffer, A Sedrakyan, J Hu Journal of Clinical Oncology 37 (7_suppl), 103-103, 2019 | 2 | 2019 |
| MP53-17 increasing incidence of infections after prostate biopsy in the United States J Shoag, M Gross*, M Pantuck, M Gorin, E Schaeffer, T Sun, A Sedrakyan, ... The Journal of Urology 201 (Supplement 4), e781-e782, 2019 | 1 | 2019 |
| CD8 T cell response and its released cytokine IFN-γ are necessary for lung alveolar epithelial repair during bacterial pneumonia X Zhang, M Ali, MA Pantuck, X Yang, CR Lin, K Bahmed, B Kosmider, ... Frontiers in Immunology 14, 1268078, 2023 | | 2023 |
| Expanding the GRK5 Interactome M Pantuck, S Rajan, E Barr, J Ibetti, J Garbincius, R Coleman, K Chuprun, ... Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
| 4: 03 PM Abstract No. 343 SIR or AUA: whose guidelines to follow? A meta-analysis of the use of minimally invasive surgical therapies and prostate artery embolization for the … S Larussa, M Pantuck, G Askin, T McClure Journal of Vascular and Interventional Radiology 31 (3), S156, 2020 | | 2020 |
